Targeted radionuclide therapy of melanoma: anti-tumoural efficacy studies of a new 131I labelled potential agent.
Bonnet-Duquennoy M, Papon J, Mishellany F, Labarre P, Guerquin-Kern JL, Wu TD, Gardette M, Maublant J, Penault-Llorca F, Miot-Noirault E, Cayre A, Madelmont JC, Chezal JM, Moins N.
Bonnet-Duquennoy M, et al.
Int J Cancer. 2009 Aug 1;125(3):708-16. doi: 10.1002/ijc.24413.
Int J Cancer. 2009.
PMID: 19437532